SII appeals to PMO with proposed reforms for the drug regulatory system

Pune-based Serum Institute of India has a written a letter to the Prime Minister’s Office (PMO) with proposed reforms which can be implemented in the drug regulatory system, which comprises of giving permit for manufacturing and stockpiling of non-Covid vaccines while subjected to clinical trials. Prakash Kumar Singh, Director of Government and Regulatory Affairs, Serum…

Read More

Covaxin depicts 81 percent efficacy for the phase 3 clinical trials: Bharat Biotech

Hyderabad-based Bharat Biotech, developed the first ‘Made in India vaccine’ called Covaxin, which has been discovered to have an efficacy of 81 per cent for the phase three clinical trials with the preliminary results as announced on Wednesday. The clinical trials involved 25,800 subjects in collaboration with the Indian Council of Medical Research (ICMR). Krishna…

Read More

Climate crisis for Indian firms estimated to cost $100 billion in the forthcoming five years: Study

For the top economic firms have estimated to have an economic effect of ₹7.14 lakh crore (around US$100 billion) for the coming five years from the risks urged by the climate crisis, as per the report by CDP (formerly Carbon Disclosure Project), an organization which functions on international disclosure systems which are for investors, cities,…

Read More

OIC has no locus standi to talk about J&K, misused by Pak says India at UNHRC

India on Tuesday strongly spoke at the UN Human Rights Council (UNHRC) with a statement going against the Organization of Islamic Cooperation (OIC) for Jammu and Kashmir, iterating that the body has no locus standi to speak for the issue. India further accused Pakistan regarding ‘misusing the august forum.” PawanKumar Badhe, First Secretary, Permanent Mission…

Read More
error: Content is protected !!